1 week Biogen Partner Eisai Gets Positive CHMP Nod for Leqembi in EuropeZacks
The CHMP renders a positive opinion recommending approval for BIIB and Eisai’s Leqembi for treating early Alzheimer’s disease.
Biogen (BIIB) · Europe · Japan
XThe CHMP renders a positive opinion recommending approval for BIIB and Eisai’s Leqembi for treating early Alzheimer’s disease.
Biogen (BIIB) · Europe · Japan
X